跳至主要内容
临床试验/NL-OMON45579
NL-OMON45579已完成不适用

Comparison between venous infliximab blood level and bloodspot-technology in children with inflammatory bowel disease. - Comparison between venous infliximab blood level and bloodspot-technology.

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
2 至 17(—)

入选标准

  • - Patients with Crohn's disease, Ulcerative Colitis and IBD-unclassified
  • - Age from six to sixteen years old
  • - Treatment with infliximab
  • - Indication to determine infliximablevel and anti-drug-antibodies
  • - Obtain informed consent

排除标准

  • - Age under six and above seventeen years old
  • - No informed consent
  • - Children and parents/guardians who do not speak the Dutch language

研究者

相似试验